Leadership Overview
Johnson & Johnson MedTech has 10 executives leading key functions including finance, human resources, operations, and global leadership.
Driven by purposeful technology, Johnson & Johnson MedTech transforms medical intervention capabilities through advanced healthcare solutions and medical devices, impacting global healthcare markets.
Driven by purposeful technology, Johnson & Johnson MedTech transforms medical intervention capabilities through advanced healthcare solutions and medical devices, impacting global healthcare markets.
Leadership Roles at Johnson & Johnson MedTech
Gigi Chang - Chief Financial Officer, Medtech (Canada)
Gigi Chang, the Chief Financial Officer, Medtech (Canada) at Johnson & Johnson MedTech, directs financial strategy and operations for the Canadian MedTech division. This leadership role involves managing budgets, forecasting financial performance, and ensuring fiscal responsibility across all Canadian operations. Chang's oversight extends to financial planning and analysis, supporting strategic decision-making to drive profitable growth within the region. The financial executive ensures compliance with all relevant financial regulations and reporting standards specific to the Canadian market. By optimizing resource allocation and identifying cost-saving opportunities, Gigi Chang strengthens the financial health of the MedTech business in Canada, aligning fiscal objectives with the company's broader mission of advancing healthcare solutions.
Tino Schweighoefer - Chief Financial Officer, Monarch Platform
Tino Schweighoefer, the Chief Financial Officer, Monarch Platform at Johnson & Johnson MedTech, spearheads the financial direction and fiscal management for the Monarch Platform. This executive oversees all financial planning, analysis, and reporting activities specifically for this advanced medical technology solution. Schweighoefer's duties include managing investment strategies, optimizing revenue streams, and ensuring the financial viability and growth of the Monarch Platform. The Chief Financial Officer works closely with product development and commercial teams to align financial resources with innovation and market expansion goals. By providing robust financial oversight and strategic guidance, Tino Schweighoefer ensures the Monarch Platform achieves its financial objectives and contributes significantly to Johnson & Johnson MedTech's overall success in transforming medical interventions.
Devi Govender - Worldwide President of Heart Recovery
Devi Govender, the Worldwide President of Heart Recovery at Johnson & Johnson MedTech, directs the global strategy and commercial operations for heart recovery solutions. This leadership position involves overseeing the development, marketing, and sales of advanced medical devices and technologies aimed at improving cardiac patient outcomes. Govender's responsibilities include driving market penetration, fostering key partnerships with healthcare providers, and ensuring the delivery of innovative solutions across global markets. The Worldwide President of Heart Recovery champions advancements in cardiovascular care, focusing on transforming intervention capabilities for patients worldwide. By leading a dedicated global team, Devi Govender ensures that Johnson & Johnson MedTech remains at the forefront of cardiac medical technology, enhancing patient recovery and quality of life.
Paolo Di Vincenzo - Global President, Trauma
Paolo Di Vincenzo, the Global President, Trauma at Johnson & Johnson MedTech, leads the worldwide business unit focused on trauma care solutions. This executive directs the strategy, product innovation, and commercial execution for a comprehensive portfolio of medical devices used in treating traumatic injuries. Di Vincenzo's purview includes overseeing global sales, marketing, and research and development efforts to advance surgical interventions in orthopedics and related fields. The Global President, Trauma ensures that Johnson & Johnson MedTech provides cutting-edge technologies that improve patient outcomes and support healthcare professionals in complex surgical procedures. By driving market leadership and fostering innovation, Paolo Di Vincenzo strengthens the company's position in the global trauma care segment.
Nisha Johnson - Global President J & J MedTech Wound Closure and Healing
Nisha Johnson, the Global President J & J MedTech Wound Closure and Healing at Johnson & Johnson MedTech, commands the global strategy and operations for wound care solutions. This executive directs the development, commercialization, and market expansion of advanced technologies designed to improve wound healing processes and patient recovery. Johnson's responsibilities encompass leading cross-functional teams, driving product innovation, and ensuring market access across diverse geographic regions. The Global President J & J MedTech Wound Closure and Healing focuses on transforming patient care through purposeful technology, addressing critical needs in surgical and chronic wound management. By championing advancements in this specialized field, Nisha Johnson reinforces Johnson & Johnson MedTech's commitment to delivering comprehensive healthcare solutions worldwide.
Oray Boston - President, Worldwide of Trauma, Extremities, Craniomaxillofacial, Animal Health & Sports Medicine
Oray Boston, the President, Worldwide of Trauma, Extremities, Craniomaxillofacial, Animal Health & Sports Medicine at Johnson & Johnson MedTech, oversees a broad spectrum of specialized medical technology divisions. This executive directs global strategy, operational execution, and market development across trauma, extremities, craniomaxillofacial, animal health, and sports medicine segments. Boston's leadership ensures the integration of innovative solutions and the expansion of market reach for these diverse product lines. The President, Worldwide of Trauma, Extremities, Craniomaxillofacial, Animal Health & Sports Medicine drives the advancement of purposeful technology to meet critical healthcare needs in these specialized areas. By fostering collaboration and strategic growth, Oray Boston enhances Johnson & Johnson MedTech's comprehensive offerings and global impact.
Steven Henn - Global President, Biosurgery
Steven Henn, the Global President, Biosurgery at Johnson & Johnson MedTech, directs the worldwide strategy and commercial operations for the biosurgery division. This executive leads the development and market introduction of advanced biological products and medical devices used in surgical procedures to enhance healing and reduce complications. Henn's responsibilities include driving innovation, expanding global market presence, and ensuring the highest standards of product quality and efficacy. The Global President, Biosurgery focuses on transforming surgical interventions through cutting-edge technology and scientific expertise. By leading a dedicated global team, Steven Henn ensures that Johnson & Johnson MedTech provides essential solutions that improve patient outcomes and support surgical teams across various medical disciplines.
Edward Zhou - President (China)
Edward Zhou, the President (China) at Johnson & Johnson MedTech, leads the company's strategic initiatives and operational management within the significant Chinese market. This executive directs all business activities, ensuring alignment with global objectives while adapting to local market dynamics and regulatory landscapes. Zhou's responsibilities include driving growth, fostering key relationships with healthcare providers and stakeholders, and overseeing the expansion of Johnson & Johnson MedTech's advanced healthcare solutions across China. The President (China) plays a crucial role in navigating the complexities of one of the world's largest healthcare markets. By championing innovation and market penetration, Edward Zhou strengthens Johnson & Johnson MedTech's presence and impact in China, contributing to its global mission.
Sword Zheng - Chief Human Resources Officer
Sword Zheng, the Chief Human Resources Officer at Johnson & Johnson MedTech, architects the global human capital strategy. This executive directs all aspects of talent management, organizational development, and employee engagement across the company's worldwide operations. Zheng's responsibilities include fostering a diverse and inclusive workplace culture, implementing innovative HR policies, and ensuring the alignment of workforce capabilities with strategic business objectives. The Chief Human Resources Officer oversees talent acquisition, retention, and development programs designed to attract and cultivate top talent in the medical technology sector. By championing employee well-being and professional growth, Sword Zheng ensures that Johnson & Johnson MedTech possesses the skilled workforce necessary to drive innovation and maintain its leadership in advanced healthcare solutions.
Yvan Francois - Chief of Staff To the Executive Vice President and WW Chain JJMedTech
Yvan Francois, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech at Johnson & Johnson MedTech, provides critical strategic support and operational coordination. This role involves managing key initiatives, facilitating communication across executive levels, and ensuring the seamless execution of the Executive Vice President's global agenda. Francois's responsibilities include driving cross-functional alignment, preparing executive briefings, and overseeing special projects that advance the company's strategic priorities in medical technology. The Chief of Staff acts as a key liaison, bridging communication gaps and ensuring operational efficiency throughout the worldwide chain of JJMedTech. By streamlining processes and enhancing executive decision-making, Yvan Francois directly contributes to the effective governance and strategic advancement of Johnson & Johnson MedTech's global operations.
Explore Leadership Teams in Manufacturing
Boston Scientific Corporation is a global medical device company headquartered in Marlborough, Massachusetts, specializing in the development, manufacture, and commercialization of minimally invasive technologies across multiple interventional specialties. Operating through MedSurg and Cardiovascular segments, the company provides advanced solutions such as catheters, stents, and cardiac devices to healthcare providers worldwide, supporting improved patient outcomes and clinical efficiency.
Company Leadership DB
BS
JC
BD
Intuitive Surgical, Inc commonly known simply as Intuitive is a global medical technology and healthcare innovation company focused on advancing minimally invasive care. The organization designs, manufactures, and markets robotic surgical systems and related instruments that enable surgeons to perform complex procedures with enhanced precision and control. Its flagship platform helps physicians and care teams optimize outcomes, improve patient experiences, and support broader access to advanced surgical care. In addition to robotics hardware, the company offers integrated digital solutions, clinical support services, and training programs that help healthcare providers leverage its technologies effectively. Intuitive collaborates closely with medical professionals worldwide to push the boundaries of minimally invasive procedures and support healthier patient journeys.
Company Leadership
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership KT
MR
Merit Medical Systems, Inc. is a prominent manufacturer and marketer specializing in proprietary disposable medical devices designed to support hospitals and healthcare providers around the world. Since its founding in the late twentieth century, the company has developed a reputation for innovation and quality in the medical device industry. Merit Medical is dedicated to understanding the needs of its clients and advancing healthcare through the development of cutting-edge products that improve patient outcomes and clinical efficiency.
Company Leadership
NP
BL
Frequently Asked Questions Regarding Johnson & Johnson MedTech Top Executives and Leadership Team
